Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
XPH
56
HOLDINGS
16%
ALSO IN SBIO
SBIO
78
HOLDINGS
12%
ALSO IN XPH
SECTOR DRIFT (XPH minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CRINETICS PHARMACEUTICALS INC | 2.0% | 2.5% | 2.0% |
|
EDGEWISE THERAPEUTICS, INC. | 2.0% | 2.1% | 2.0% |
|
TARSUS PHARMACEUTICALS, INC. | 1.9% | 1.8% | 1.8% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.0% | 1.1% | 1.1% |
|
RAPPORT THERAPEUTICS INC | 1.4% | 1.0% | 1.0% |
XPH Overweight Relative to SBIO
|
ENLIVEN THERAPEUTICS, INC. | 2.7% |
|
ORGANON & CO. | 2.6% |
|
CORCEPT THERAPEUTICS INC | 2.3% |
|
DEFINIUM THERAPEUTICS INC | 2.1% |
|
TERNS PHARMACEUTICALS, INC. | 2.1% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
 |
PERRIGO CO | 2.1% |
|
TREVI THERAPEUTICS, INC. | 2.0% |
|
INNOVIVA, INC. | 2.0% |
|
JAZZ PHARMACEUTICALS PLC | 1.9% |
XPH Underweight Relative to SBIO
|
KYMERA THERAPEUTICS, INC. | -4.2% |
|
MIRUM PHARMACEUTICALS, INC. | -3.4% |
|
CG ONCOLOGY, INC. | -3.4% |
|
ALKERMES PLC | -3.3% |
|
CELCUITY INC. | -3.2% |
|
APELLIS PHARMACEUTICALS, INC. | -3.1% |
|
APOGEE THERAPEUTICS, INC. | -2.9% |
|
AMICUS THERAPEUTICS INC | -2.7% |
|
SPYRE THERAPEUTICS INC | -2.4% |
|
NEWAMSTERDAM PHARMA CO NV | -2.4% |